- Former radio personality Radene Marie Cook rues 'fail first' treatment plans for chronic pain
- Ensuring access to chronic pain medications
- Study: Whooping cough vaccine may not prevent infection
- CDC study: Severe diarrheal illness in children linked to prescribed antibiotics
- Chickenpox vaccine does not appear to increase incidence of shingles, study finds
PITTSBURGH — The Food and Drug Administration has approved a new drug for genital herpes made by Mylan, the drug maker said Wednesday.
Mylan announced the approval of acyclovir ointment in the 5% strength. The drug is a generic version of Valeant International's Zovirax, used to manage initial genital herpes and in limited, non-life-threatening mucocutaneous herpes simplex virus infections in patients with compromised immune systems.
Various versions of the drug had sales of about $230 million in 2012, according to IMS Health. Mylan said it would start shipping the drug immediately.